Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Trial of ALGRX 4975 in Subjects With Painful Intermetatarsal Neuroma

NCT00130962 is registered in ClinicalTrials.gov with AlgoRx Pharmaceuticals as lead sponsor.

NCT NCT00130962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Trial of ALGRX 4975 in Subjects With Painful Intermetatarsal Neuroma
Lead sponsor
AlgoRx Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
February 28, 2006
Enrollment
60
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neuroma